Skip to main content

Walsh Colin's Form 4 filing

Attovia Therapeutics, Inc. (ATTO) · filed Aug 13, 2026

Accession no.
0001866174-26-000009
Filed
Aug 13, 2026, 9:52 PM ET
Trade date
Aug 5-6, 2026
Filing delay
8 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 27 non-derivative transactions and 2 derivative transactions. Open-market purchases total $10.3M. Open-market sales total $2.25M. It was filed 8 days after the trade, past the 2-business-day deadline.

This filing was later replaced by the amendment 0001866174-26-000011 (Aug 28, 2026). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walsh ColinCIK 0001866174Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 5, 2026Common StockPPurchaseAcquired+85,000$21.00+$1,785,00085,000Indirect
Aug 5, 2026Common StockSSaleDisposed−988$22.03−$21,765.6484,012Indirect
Aug 5, 2026Common StockSSaleDisposed−447$21.87−$9,775.8983,565Indirect
Aug 5, 2026Common StockSSaleDisposed−1,332$22.03−$29,343.9682,233Indirect
Aug 5, 2026Common StockSSaleDisposed−200$22.05−$4,41082,033Indirect
Aug 5, 2026Common StockSSaleDisposed−1,556$22.06−$34,325.3680,477Indirect
Aug 5, 2026Common StockSSaleDisposed−3,402$22.02−$74,912.0477,075Indirect
Aug 5, 2026Common StockSSaleDisposed−200$22.10−$4,42076,875Indirect
Aug 5, 2026Common StockSSaleDisposed−480$21.55−$10,34476,395Indirect
Aug 5, 2026Common StockSSaleDisposed−100$22.11−$2,21176,295Indirect
Aug 5, 2026Common StockSSaleDisposed−753$21.97−$16,543.4175,542Indirect
Aug 5, 2026Common StockSSaleDisposed−672$22.02−$14,797.4474,870Indirect
Aug 5, 2026Common StockSSaleDisposed−6,970$22.03−$153,549.167,900Indirect
Aug 5, 2026Common StockSSaleDisposed−400$22.02−$8,80867,500Indirect
Aug 5, 2026Common StockSSaleDisposed−1,180$21.84−$25,771.266,320Indirect
Aug 5, 2026Common StockSSaleDisposed−1,040$22.05−$22,93265,280Indirect
Aug 5, 2026Common StockSSaleDisposed−300$20.84−$6,25264,980Indirect
Aug 5, 2026Common StockSSaleDisposed−443$21.78−$9,648.5464,537Indirect
Aug 5, 2026Common StockSSaleDisposed−200$22.05−$4,41064,337Indirect
Aug 5, 2026Common StockSSaleDisposed−700$22.07−$15,44963,637Indirect
Aug 5, 2026Common StockSSaleDisposed−1,163$22.19−$25,806.9762,474Indirect
Aug 5, 2026Common StockSSaleDisposed−100$21.99−$2,19962,374Indirect
Aug 5, 2026Common StockSSaleDisposed−6,763$21.61−$146,148.4355,611Indirect
Aug 5, 2026Common StockSSaleDisposed−76,418$21.04−$1,607,834.720Indirect
Aug 6, 2026Common StockCConversionAcquired+1,957,134$0.00$02,042,134Indirect
Aug 6, 2026Common StockCConversionAcquired+478,498$0.00$02,520,632Indirect
Aug 6, 2026Common StockPPurchaseAcquired+500,000$17.00+$8,500,0003,020,632Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2026Common StockCConversionDisposed−1,957,134$0.00$00Indirect
Aug 6, 2026Common StockCConversionDisposed−478,498$0.00$00Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)